The latest precision medicine news

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court...read more

Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

Partnership will build a global AI-powered healthcare platform to deliver more effective, scalable, and affordable care Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a...read more

How Marketing Automation Effectively Tracks Lead Acquisition Attribution

I wanted to provide some guidance and best practices around marketing automation attribution models, which I hope will be helpful and gives you some insight. I’m sure we all embrace data-driven marketing. That said, in...read more

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use...read more

AI model trained on de-identified data from 57 million people

An artificial intelligence (AI) model is being trained on a set of NHS data for 57 million people in England, from which personal information has been stripped away, in a world-first pilot project run by researchers at...read more

A Look at Human Longevity & Life Expectancy

Driven by a personal interest in human longevity, I’ve explored the extensive discourse surrounding this topic. It’s a subject that captivates both the general public and the scientific community, whether...read more

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information...read more

Cloud for AI/ML & Modern Data Science

The Bio-IT World Conference & Expo, taking place in Boston, April 2-4, has grown into a highly regarded, must-attend conference for life scientists, clinical care, and IT professionals. The program focuses on new...read more

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level...read more

Exciting Advancements in AI Genomic Modeling

A recent paper that has been generating energetic discussions and debate about Artificial Intelligence (AI), and its implications for biological discovery was published on the bioRxiv site on Feb 21 of this year (Brixi...read more

Largest ever DNA sequencing dataset on UK child development studies available

For the first time, large-scale DNA sequence data on three UK long-term birth cohorts has been released, creating a unique resource to explore the relationship between genetic and environmental factors in child health...read more

AGBT 2025 – And the Winner is, Drum Roll, Sequencing

While a lot more than “sequencing” has been the news from AGBT 2025, with this post I wanted to focus predominantly on some highlights from the “sequencing” category. Clearly, Roche’s SBX Nanopore Sequencing stole the...read more

Roche – Inventing SBX, a DNA Sequencing Breakthrough

A blurry band on a gel during a chemistry experiment didn’t show conclusive results, but there was still enough there to warrant further exploration. Years before, biochemist Mark Kokoris and his colleagues had begun a...read more

Roche has unveiled its proprietary Sequencing by Expansion (SBX) technology

Marking its return to the next-generation sequencing (NGS) space. SBX introduces a new biochemical approach designed to address the limitations of current sequencing technologies, particularly in speed, scalability, and...read more

2024 in Review

2024 was a true testimony to the fact that we are positioned at the intersection of significant AI opportunities and this in parallel to trends in declining costs of next-generation sequencing (NGS): healthcare...read more

The Multifaceted and Sometimes Paradoxical Nature of Reactive Oxygen Species in Cancer

Reactive oxygen species (ROS) are a feature of all living eukaryotic cells, normal or cancerous. Maintaining redox homeostasis is a complex and delicate balance involving numerous biochemical production and defense...read more

Dense SNP-based analyses complement forensic anthropology biogeographical ancestry assessments

Comparisons between anthropological and genomic ancestry assignments for UHRs reveals significant discordance, shedding light on the challenges in determining population affinity, particularly for admixed populations...read more

Prioritizing privacy and presentation of supportable hypothesis testing in forensic genetic genealogy investigations

Protecting the genetic privacy of folks that help solve crimes or identify human remains, is of the utmost importance to Othram, the world’s first private DNA laboratory built specifically to apply the power of modern...read more

The Importance of Investment in Multimodal Data in the AI Era

As the artificial intelligence (AI) revolution picks up momentum, it is important for us not to lose focus on innovation within the healthcare data ecosystem. We stand at the brink of a transformative era where the deep...read more

‘All of Us’ Research Program Identifies 275 Million New Genetic Variants

Study details the unprecedented scale, diversity, and power of the All of Us Research Program Researchers have discovered more than 275 million previously unreported genetic variants, identified from data shared by...read more

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Contact me to get the spreadsheet with full data I used for my analysis. As a CEO of an early-stage biotech company (Neurolentech) operating in the spaceof neurodevelopmental diseases (NDDs), I spend a significant part...read more

Novel Genetic Priority Score (GPS) Unveiled to Enhance Target Prioritization in Drug Development

Innovative approach integrates genetic data to identify drug targets with high potential for clinical trial success Researchers optimized drug target prioritization to increase odds of clinical trial success by...read more

The FDA’s Center for Drug Evaluation and Research (CDER) Approved 55 New Drugs in 2023

The Small Molecule and Biologic Pharmacopoeia Continues to Grow This cohort is nearly 50% bigger than the new approval class of 2022 (see Figure 1). Figure 1: 30 years of novel FDA approvals. Annual numbers of...read more

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

2023 was quite year, to say the least! Among the things that we witnessed: The second biggest bank collapse in US history, layoffs across biotech, AI/ChatGPT dominated the scene, AlphaFold received the Lasker price...read more

2023 Watch List: Top 10 Precision Medicine Technologies and Issues

CADTH routinely identifies new and emerging technologies that are likely to have a significant and meaningful impact on Canada’s health care systems. CADTH’s annual watch lists specifically identify technologies that...read more

L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration

The Result Is An Automated, Highly Efficient, and Cost Effective Lab Management Process This month’s “Company Spotlight” provides a closer look at L7 Informatics, the provider of a scientific process and data management...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.